GLAMOR-PM Tablets

First-line Therapy with a Steady & Solid Combination to Manage Diabetes

COMPOSITION – Glimepiride IP 2 mg + Metformin Hydrochloride IP 500 mg (SR) + Pioglitazone Hydrochloride IP 15 mg

Category:

Description

  • The triple combination shows a reduction in parameters like mean fasting blood glucose (41% reduction); and the mean glycosylated hemoglobin (26% reduction).

Composition

Glimepiride IP 2 mg + Metformin Hydrochloride IP 500 mg (SR) + Pioglitazone Hydrochloride IP 15 mg